PMID- 24070185 OWN - NLM STAT- MEDLINE DCOM- 20140401 LR - 20220408 IS - 1471-230X (Electronic) IS - 1471-230X (Linking) VI - 13 DP - 2013 Sep 26 TI - Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study. PG - 143 LID - 10.1186/1471-230X-13-143 [doi] AB - BACKGROUND: The association between obesity and Barrett's esophagus (BE) in the Japanese population remains unclear. The prevalence of BE and its associated risk factors was examined. METHODS: A cross-sectional study of 1581 consecutive individuals who underwent upper gastrointestinal endoscopy was conducted. The prevalence of endoscopically suspected BE (ESBE) was evaluated. Obesity was evaluated by body mass index (BMI, >/= 25 kg/m2) and waist circumference (WC) (males, >/= 85 cm; females, >/= 90 cm). Because endoscopic diagnosis of ultra-short ESBE (<1 cm in extent) is difficult and highly unreliable, this type of ESBE was excluded from the study. RESULTS: In proton pump inhibitor (PPI) non-users, the prevalence of ESBE >/= 1 cm was 5.6%. In univariate analysis, male sex and reflux esophagitis (RE) were significantly associated with BE, but BMI, WC, and reflux symptoms were not. In multivariate logistic regression analysis, only RE (odds ratio [OR] = 3.48, 95% confidence interval [CI] 1.89-6.41, p < 0.0001) was an independent risk factor for BE; obesity and the other factors were not. In contrast, RE (OR 5.67, p = 0.0004) and large WC (OR 5.09, p = 0.0005) were significant risk factors for ESBE >/= 1 cm in PPI users. Only male sex, but not obesity or the other risk factors, was associated with an increased risk of RE in patients not taking PPIs. CONCLUSIONS: RE, but not obesity, may have an independent association with the risk of ESBE in the Japanese population. Furthermore, obesity measures were not independent risks for RE. Interestingly, PPI-refractory RE and large WC were risk factors for ESBE >/=1 cm in patients taking PPIs. FAU - Watari, Jiro AU - Watari J AD - Division of Upper Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya 663-8501, Japan. watarij@hyo-med.ac.jp. FAU - Hori, Kazutoshi AU - Hori K FAU - Toyoshima, Fumihiko AU - Toyoshima F FAU - Kamiya, Noriko AU - Kamiya N FAU - Yamasaki, Takahisa AU - Yamasaki T FAU - Okugawa, Takuya AU - Okugawa T FAU - Asano, Haruki AU - Asano H FAU - Li, Zhao Liang AU - Li ZL FAU - Kondo, Takashi AU - Kondo T FAU - Ikehara, Hisatomo AU - Ikehara H FAU - Sakurai, Jun AU - Sakurai J FAU - Tomita, Toshihiko AU - Tomita T FAU - Oshima, Tadayuki AU - Oshima T FAU - Fukui, Hirokazu AU - Fukui H FAU - Miwa, Hiroto AU - Miwa H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130926 PL - England TA - BMC Gastroenterol JT - BMC gastroenterology JID - 100968547 RN - 0 (Proton Pump Inhibitors) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Barrett Esophagus/*epidemiology MH - Body Mass Index MH - Cross-Sectional Studies MH - Esophagitis, Peptic/*epidemiology MH - Esophagoscopy MH - Female MH - Gastroesophageal Reflux/epidemiology MH - Humans MH - Japan/epidemiology MH - Logistic Models MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Obesity/*epidemiology MH - Obesity, Abdominal/epidemiology MH - Odds Ratio MH - Proton Pump Inhibitors/therapeutic use MH - Risk Factors MH - Sex Factors MH - Waist Circumference MH - Young Adult PMC - PMC3849380 EDAT- 2013/09/28 06:00 MHDA- 2014/04/02 06:00 PMCR- 2013/09/26 CRDT- 2013/09/28 06:00 PHST- 2013/03/17 00:00 [received] PHST- 2013/09/20 00:00 [accepted] PHST- 2013/09/28 06:00 [entrez] PHST- 2013/09/28 06:00 [pubmed] PHST- 2014/04/02 06:00 [medline] PHST- 2013/09/26 00:00 [pmc-release] AID - 1471-230X-13-143 [pii] AID - 10.1186/1471-230X-13-143 [doi] PST - epublish SO - BMC Gastroenterol. 2013 Sep 26;13:143. doi: 10.1186/1471-230X-13-143.